President Donald Trump announced Friday that the most-favored-nation (MFN) prices on prescription drugs in deals he struck with pharmaceutical companies are officially being extended to Medicaid programs in all 50 states, Washington, DC, and Puerto Rico.

Trump announced the action in the Oval Office on Friday.

“Thank you all for being here today as we take historic action to officially extend the benefits of our most-favored-nation agreements on prescription drug prices to state Medicaid programs all across the nation,” he said.

“This will save states billions and billions of dollars per year on drugs and allow them to invest those savings in…

Read the full article at BREITBART.COM